Press Release

Theralase Demonstrates Bacteria Destruction in Low Oxygen Environments
Press Release
Written by TAC Staff   
Thursday, 13 February 2014 11:04
Unique Characteristics of New Photo Dynamic Compounds has Application in Destruction of Lung, Breast, Brain, Bladder and Prostate Cancers

Toronto, Ontario – February 13, 2014 - Theralase Technologies Inc. (TSXV: TLT) reported today that a recently published scientific paper demonstrated that its new family of Photo Dynamic Compounds (PDCs) has been proven to significantly destroy 2 types of bacteria (Staphylococcus aureus (s. aureus) and Methicillin Resistant Staphylococcus aureus (MRSA)) in low oxygen atmospheres. The results are considered pivotal because the Theralase PDCs efficacy has been validated in both normal and low oxygen environments. Since the Theralase PDC platform technology is able to be used in both bacteria and cancer destruction, the described technology is offering a new paradigm for destruction of low oxygenated cancerous tumours. (Photodiagnosis Photodyn Ther. Dec;10(4):615-25). 

“The ability for the PDC technology to be effective in low oxygen environments is considered to be an essential factor in the recurrence and progression of non-muscle invasive bladder cancer. This form of disease represents up to 75% of newly diagnosed bladder cancer cases accounting for more than 386,000 cases and 150,000 deaths annually worldwide,” said Dr. Arkady Mandel, Chief Scientific Officer of Theralase Inc. Dr. Mandel continued: “The abnormal decrease or the lack of oxygen supply to cells and tissues is called hypoxia and commonly presents in solid cancers, such as brain, bladder, breast, lung and prostate. Hypoxic cancers are extremely aggressive, resistant to standard therapies (chemotherapy and radiotherapy), and thus very difficult to destroy. Tumor hypoxia is known to play a role in cancer metastasis (spread) and resistance to therapy, as well as the ability of cancer cells to escape destruction by the immune system. The evidence supporting the Theralase PDC technology represents a potential solution for hypoxic cancers. In our work, we described a family of Theralase PDCs that have shown an ability to switch their photoreactivity from a Type II reaction (oxygen dependent) to a Type I (free radical mediated) reaction. This is strategic to the Company in that a Type I reaction is unique and opens the opportunity of using the PDCs beyond sterilization and the treatment of superficial cancerous lesions to the treatment of harder to treat tumours”.

Dr. Lothar Lilge, Senior Scientist  at the Princess Margaret Cancer Centre, University Health Network stated that, “In well oxygenated environments, these new PDCs generate singlet oxygen, a dominant cytotoxic substance with close to 100% efficacy, yet under hypoxia (low oxygen) conditions, they display the remarkable ability to switch to a Type I or oxygen independent cytotoxic substance owing to their ability to simultaneously act as an excited state oxidant and reductant. The intrinsic positive charge of the Ru(II) metal combined with the oxygen independent light activated cytotoxicity demonstrated by this family of PDCs opens a new strategy for destroying both gram-positive and gram-negative bacteria regardless of oxygenation level.  Therefore, this has a significant impact on the destruction of cancer cells by PDC technology, as a considerable fraction of cancer will survive in low oxygen environments and according to the literature this is one of the causes for recurrence of cancer post therapy.” 

Dr. Michael Jewett, Clinical Principal Scientific Investigator at Princess Margaret Cancer Centre, University Health Network and University of Toronto stated that, “I am extremely encouraged by the results of this scientific work and the implications that it may have in the destruction of bladder Transitional Cell Carcinoma, as the bladder is traditionally known as a very low oxygen environment. There has not been a new drug approved for bladder cancer since 1998 and I am looking forward to working with the Theralase team to initiate a Phase 1 / 2 clinical trial in 1Q2015.”

About Theralase Technologies Inc.
Theralase Technologies Inc. designs, manufactures and markets patented, superpulsed laser technology used in healing injured tissue and destroying cancer.  Theralase technology is safe and effective in eliminating pain, reducing inflammation and accelerating tissue regeneration of numerous nerve, muscle and joint injuries. Theralase is actively developing patented technology that is able to target and destroy cancers, bacteria and viruses when light activated. 

Additional information is available at and 
This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information, please contact:
Roger Dumoulin-White,  
President & CEO
416-699-LASE (5273) ext. 225
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Essential Formula’s Line of Chia Omega Formulations Receives Respected NSF Certified for Sport® Product Certification
Press Release
Written by TAC Staff   
Friday, 07 February 2014 15:11
DALLAS, January 29, 2014 - Essential Formulas Incorporated’s line of award-winning CHIA OMEGA® formulations recently earned the NSF Certified for Sport® designation  ( from NSF International, one of the most respected independent product testing and certification organizations.

Scientists at NSF International tested Essential Formulas’ CHIA OMEGA products ( to verify that these products comply with strict standards of NSF/ANSI 173, the only American national standard for dietary supplements which was developed through a consensus process involving input from regulatory, industry, sports and consumer groups.  This included testing to verify label accuracy and that the product did not contain any harmful levels of contaminants.

chia-omegaAdditionally, to earn NSF Certified for Sport® certification, CHIA OMEGA products were screened for more than 180 banned substances such as narcotics, steroids, stimulants, hormones and other related substances along with diuretics and other masking agents.  Essential Formulas’ manufacturing facility also was inspected to verify compliance with NSF’s current Good Manufacturing Practices (cGMP) facility registration program.

“This distinguished certification helps athletes as well as general consumers make more educated decisions when choosing dietary supplements,” said Michael Schoor, President and CEO of Essential Formulas.  “Our company was founded on the principles of transparency, education and product integrity and we are proud to earn the highly respected NSF Certified for Sport® designation for our CHIA OMEGA products.”

“Many professional athletes and sports organizations rely on NSF International’s Certified for Sport® program because it is the most rigorous testing and certification program available for sports nutrition and dietary supplement products,” said Lisa Thomas, General Manager of NSF’s Dietary Supplement programs.  “Essential Formulas’ participation in the program demonstrates their leadership and commitment in developing products of high quality and safety.”

The National Football League (NFL), Major League Baseball (MLB), National Hockey League (NHL), the Ladies Professional Golf Association (LPGA), PGA and the Canadian Centre for Ethics in Sport (CCES) utilize the NSF Certified for Sport® program to protect athletes from prohibited substances.

Athletes and consumers can find Essential Formulas’ NSF certified products on NSF International’s listings or by downloading the NSF Sport app.

About NSF International ( Based in Ann Arbor, Mich., USA, NSF International is a global independent public health organization that writes standards, and tests and certifies products for the food, water, health sciences and consumer goods industries.  Established in 1944, NSF is committed to protecting human health and safety worldwide and operates in more than 150 countries.  NSF International has been collaborating with the World Health Organization since 1997 in water quality and safety, food safety and indoor environments.

The NSF Health Sciences Division offers training and education, consulting, auditing, GMP and GLP testing, GMP facility registration, product certification, R&D and regulatory guidance for the pharmaceutical, medical device and dietary supplement industries throughout the product lifecycle.  The division also supplies pharmaceutical secondary reference standards, traceable to USP and EP standards. NSF wrote the only accredited American National Standard (NSF/ANSI 173) that verifies the health and safety of dietary supplements and also tests and certifies products to this standard. The NSF Health Sciences Division operates globally throughout North America, Europe, the Middle East, Africa, Asia and Latin America.

About Essential Formulas ( Dallas-based Essential Formulas Incorporated (EFI) was established in 2000 as the sole U.S. distributor of world-renowned microbiologist Dr. Iichiroh Ohhira’s award-winning probiotic dietary supplements.  A family-owned and operated business, EFI was founded on the philosophy of providing high-quality preventative, supportive and comprehensive pro-health products for the entire family.  Pledging to provide premium all natural supplements and exceptional customer care, EFI continually strives to lead the industry in customer and retailer education in the use and efficacy of their innovative products, which include Dr. Ohhira’s Probiotics®formulations and the newly introduced CHIA OMEGA line of Omega-3 formulations.  Both Dr. Ohhira’s Probiotic formulations and CHIA OMEGA dietary supplements are available at Vitamin Shoppe, Whole Foods Markets and other fine health food stores across the country.  For more information, visit:, or call 972.255.3918.
Significantly Reduce Lower Back Pain without Surgery or Drugs
Press Release
Written by TAC Staff   
Thursday, 06 February 2014 14:54
fitnesstherapeutics240Portland, OR –Fitness Therapeutics Inc announces release of their new product Back in Action 1, a program designed to reduce lower back pain. It was developed for people with chronic pain or those who experience repeated acute injury to their back. The program, created by Dr. Bruce Farmer MD, is based on Trizone Movement Therapy™, a whole-body approach to personal health. The movements have been scientifically proven to reduce pain, restore fitness, and increase mobility by participants.

Fitness Therapeutics is a local company focused on home-based, whole body movement routines that are designed to restore balance, increase symmetry in the body and significantly reduce pain. The company offers several programs to relieve lower back pain, designed to be used in the comfort of one’s own home. They also offer fitness therapy, movement and walking classes at their Portland based headquarters.

Back in Action 1 is available at
Biofreeze® Web-based Referral and Sampling Program Drives New Patients
Press Release
Written by TAC Staff   
Thursday, 06 February 2014 14:48
“We are very excited to introduce the newest element of our Biofreeze® sampling program, the extremely successful program that supports practitioners in bringing new patients through their door,” stated Ethan Pochman, Vice President, US Clinical, Performance Health. “With our new online sampling application, we accept consumer requests for free Biofreeze samples and provide those requests to practitioners in the consumer’s area. This creates an opportunity for the practitioner to introduce both Biofreeze and their practice to someone looking for pain relief; someone likely to become a new patient.”

biofreeze-sample-cardTo participate in the program, practitioners need to enroll in the Biofreeze Where-to-Buy Referral Service at and order a supply of free Biofreeze samples.

With this newest Biofreeze sample request application, registered practitioners can inexpensively yet efficiently expand their marketing efforts. The practitioner is provided with the consumer’s name, phone number, mailing address and e-mail address. They put together a simple envelope with the free sample that has been customized for their practice and some great information about their practice. Now they have a very low cost, yet very targeted marketing piece and have started a conversation with a potential patient, someone who has already indicated a need for pain relief by requesting a free Biofreeze sample.

“As the number one topical analgesic, we receive the kind of web traffic that can create hundreds of leads a month for a single practitioner,” concluded Pochman. “We know practitioners are excited about new patients so we encourage them to call 800-Biofreeze. We will explain everything they need so that they can start to take advantage of this program and bring potential new patients to their door.”

Miami Chiropractic Conference
Press Release
Written by TAC Staff   
Thursday, 06 February 2014 14:40
The third annual Miami Chiropractic Conference will be held at the Doubletree Hotel, Miami Airport Convention Center, March 14-16, 2014.  The conference provides up to 30 hours of continuing education credit for chiropractors in 40 states and Canada.  The three day conference features some of the top speakers in the chiropractic profession and a wide variety of clinical and business classes are offered.  The schedule includes multiple options for Florida ‘Required’ classes.   In addition, the conference Expo includes a number of chiropractic industry sponsors and vendors.

Page 18 of 38
TAC Cover
TCA Cover
BL Cover
Buyers Guide

Click on image above
to view the
Digital Edition






TAC Publications

The American Chiropractor Magazine: Digital Issues | Past Issues | Buyer's Guide


More Information

TAC Editorial: About | Circulation | Contact

Sales: Advertising | Subscriptions | Media Kit